Abstract
Tripartite motif (TRIM) family members participate in a variety of cellular activities, such as intracellular signaling, development, cellular death, protein quality control, immunological defense, waste degradation, and the emergence of cancer. These proteins usually act as E3 ubiquitin ligase. The final line of resistance against infectious viruses is a cytosolic ubiquitin ligase and antibody receptor called TRIM containing 21. TRIM21, a protein with a tripartite structure, has been linked to autoimmune erythematosus, Sjogren’s disorder, and innate immunity. TRIM21 may either promote the formation of specific cancer-activating proteins, resulting in their proteasomal degradation, or it may do neither, depending on the kind of cancer and cancer-causing trigger. The current research has shown that the antiviral action of TRIM mostly depends on their role as E3-ubiquitin ligases and a significant portion of the TRIM family mediates the transmission of innate immune cell signals and the subsequent production of cytokines. We highlighted the function of TRIM family members in various inflammatory diseases.
Similar content being viewed by others
References
Acres B, Paul S, Haegel-Kronenberger H, Calmels B, Squiban P (2004) Therapeutic cancer vaccines. Curr Opin Mol Ther 6(1):40–47
Ahuja D, GoyalP A, Ray S (2016) Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress. RNA Biol 13(11):1152–1165
Alomari M (2021) TRIM21–a potential novel therapeutic target in cancer. Pharmacol Res 165:105443
Balaji S, Ahmed M, Lorence E, Yan F, Nomie K, Wang M (2018) NF-κB signaling and its relevance to the treatment of mantle cell lymphoma. J Hematol Oncol 11(1):1–11
Betin VMS, Lane JD (2009) Atg4D at the interface between autophagy and apoptosis. Autophagy 5(7):1057–1059
Brauner S, Ivanchenko M, Thorlacius G, Ambrosi A, Wahren-Herlenius M (2018) The Sjögren’s syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production. Clin Exp Immunol 194(3):315–326
Brooks CL, Gu W (2011) p53 regulation by ubiquitin. FEBS Lett 585(18):2803–2809
Cavazzana I, Franceschini F, Quinzanini M, Manera C, Del Papa N, Maglione W, Comina D, Radice A, Sinico R, Cattaneo R (2006) Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Clin Exp Rheumatol 24(1):59
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404
Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M (2017) A method for the acute and rapid degradation of endogenous proteins. Cell 171(7):1692–1706
Di Rienzo M, Romagnoli A, Antonioli M, PiacentiniG M, Fimia M (2020) TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses. Cell Death Differ 27(3):887–902
Dickson C, Fletcher AJ, Vaysburd M, Yang JC, Mallery DL, Zeng J, Johnson CM, McLaughlin SH, Skehel M, Maslen S (2018) Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21. Elife 7:e32660
Foss S, Bottermann M, Jonsson A, Sandlie I, JamesJ LC, Andersen T (2019) TRIM21—from intracellular immunity to therapy. Front Immunol 10:2049
Frank M, Itoh K, Fujisaku A, Pontarotti P, Mattei M, Neas B (1993) The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 52(1):183
Fugger L, Jensen LT, Rossjohn J (2020) Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell 181(1):63–80
Fukuda-Kamitani TK, Kamitani T (2002) Ubiquitination of Ro52 autoantigen. Biochem Biophys Res Commmun 295(4):774–778
Gao X, Xu F, Zhang HT, Chen M, Huang W, Zhang Q, ZengLiu QL (2016) PKCα–GSK3β–NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis. Biochem Cell Biol 94(3):256–264
Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, Quarneti C, Cipriano V, DeMolo C (2007) Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 26(6):831–838
Guha A, Ahuja D, Mandal SD, Parasar B, Deyasi K, Roy D, Sharma V, Willard B, GhoshP A, Ray S (2019) Integrated regulation of HuR by translation repression and protein degradation determines pulsatile expression of p53 under DNA damage. Iscience 15:342–359
Hatakeyama S (2011) TRIM proteins and cancer. Nat Rev Cancer 11(11):792–804
Hatakeyama S (2017a) TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci 42(4):297–311. https://doi.org/10.1016/j.tibs.2017.01.002
Hatakeyama S (2017b) TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci 42(4):297–311
Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18(18):2195–2224
Hock A, Vousden KH (2010) Regulation of the p53 pathway by ubiquitin and related proteins. Int J Biochem Cell Biol 42(10):1618–1621
Hu J, Ding X, Tian S, Chu Y, Liu Z, Li Y, Li X, Wang G, WangWang LZ (2021) TRIM39 deficiency inhibits tumor progression and autophagic flux in colorectal cancer via suppressing the activity of Rab7. Cell Death Dis 12(4):391
Infantino M, Manfredi M, Grossi V, Benucci M, Morozzi G, Tonutti E, Tampoia M, Bizzaro N (2017) An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: the key role of anti-Ro52 antibodies. Clin Chim Acta 475:15–19
James LC, Keeble AH, Khan Z, RhodesTrowsdale DAJ (2007) Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci 104(15):6200–6205
Jauharoh SNA, Saegusa J, Sugimoto T, Ardianto B, Kasagi S, Sugiyama D, Kurimoto C, Tokuno O, Nakamachi Y, Kumagai S (2012) SS-A/Ro52 promotes apoptosis by regulating Bcl-2 production. Biochem Biophys Res Commun 417(1):582–587
Jefferies C, Wynne C, Higgs R (2011) Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 11(9):617–625
Jin Y, Zhao X, Zhang Q, Zhang Y, Fu X, HuWan XY (2020) Cancer-associated mutation abolishes the impact of TRIM21 on the invasion of breast cancer cells. Int J Biol Macromol 142:782–789
Jones EL, LaidlawL SM, Dustin B (2021) TRIM21/Ro52-roles in innate immunity and autoimmune disease. Front Immunol 12:738473
Keeble AH, Khan Z, ForsterL A, James C (2008) TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci 105(16):6045–6050
Keown JR, Yang JX, DouglasD J, Goldstone C (2016) Characterisation of assembly and ubiquitylation by the RBCC motif of Trim5α. Sci Rep 6(1):26837
Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599–1603
Lee JT, Gu W (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17(1):86–92
Liu Y, Lagowski JP, Gao S, Raymond JH, White CR, Kulesz-Martin MF (2010) Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. J Invest Dermatol 130(5):1384–1390
Liu Y, Wang Z, De La Torre R, Barling A, Tsujikawa T, Hornick N, Hanifin J, Simpson E, WangSwanzey YE (2017) Trim32 deficiency enhances Th2 immunity and predisposes to features of atopic dermatitis. J Invest Dermatol 137(2):359–366
Mallery DL, McEwan WA, Bidgood SR, Towers GJ, JohnsonL CM, James C (2010) Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci 107(46):19985–19990
Massagué J (2004) G1 cell-cycle control and cancer. Nature 432(7015):298–306
McEwan WA, James LC (2015) TRIM21-dependent intracellular antibody neutralization of virus infection. Prog Mol Biol Transl Sci 129:167–187
Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147(4):728–741
MüLLER J, Maurer V, Reimers K, Vogt PM, Bucan V (2015) TRIM21, a negative modulator of LFG in breast carcinoma MDA-MB-231 cells in vitro. Int J Oncol 47(5):1634–1646
Napolitano L, Meroni MG (2012) TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life 64(1):64–71
Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, KammH MA, de Silva J (2015) Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64(7):1063–1071
Niida M, TanakaKamitani MT (2010) Downregulation of active IKKβ by Ro52-mediated autophagy. Mol Immunol 47(14):2378–2387
Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T, Todo S, Hatakeyama S (2011) TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers. Carcinogenesis 32(7):995–1004
Ozato K, Shin DM, ChangH TH, Morse C III (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8(11):849–860
Papadopoulos C, Meyer H (2017) Detection and clearance of damaged lysosomes by the endo-lysosomal damage response and lysophagy. Curr Biol 27(24):R1330–R1341
Perera S, Holt MR, MankooGautel BSM (2011) Developmental regulation of MURF ubiquitin ligases and autophagy proteins nbr1, p62/SQSTM1 and LC3 during cardiac myofibril assembly and turnover. Dev Biol 351(1):46–61
Pizon V, Rybina S, Gerbal F, Delort F, Vicart P, Baldacci G, Karsenti E (2013) MURF2B, a novel LC3-binding protein, participates with MURF2A in the switch between autophagy and ubiquitin proteasome system during differentiation of C2C12 muscle cells. PLoS ONE 8(10):e76140
Reddy BA, van der Knaap JA, Bot AG, Mohd-Sarip A, Dekkers DH, Timmermans MA, Martens JW, DemmersC JA, Verrijzer P (2014) Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization. Mol Cell 53(3):458–470
Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S (2001) The tripartite motif family identifies cell compartments. EMBO J 20(9):2140–2151
Rutjes S, Vree Egberts W, Jongen P, Van Den Hoogen F, Pruijn G, Venrooij W (1997) Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109(1):32–40
Sabile A, Meyer AM, Wirbelauer C, Hess D, Kogel U, Scheffner M, Krek W (2006) Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein. Mol Cell Biol 26(16):5994–6004
Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thorén P, Herlenius E, Wahren-Herlenius M (2005) Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201(1):11–17
Sartor RB, Wu GD (2017) Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterol 152(2):327–339
Sparrer KM, Gableske S, Zurenski MA, Parker ZM, Full F, Baumgart GJ, Kato J, Pacheco-Rodriguez G, Liang C, Pornillos O (2017) TRIM23 mediates virus-induced autophagy via activation of TBK1. Nat Microbiol 2(11):1543–1557
Stevenson M (2004) TRIMming HIV-1’s mainsail. Nat Immunol 5(4):355–356
Strandberg L, Ambrosi A, Espinosa A, Ottosson L, Eloranta ML, Zhou W, Elfving Å, Greenfield E, Kuchroo VK, Wahren-Herlenius M (2008) Interferon-α induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J Clin Immunol 28:220–231
Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci 101(16):6062–6067
Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, Rocca R (2013) Human NK cells selective targeting of colon cancer–initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol 190(5):2381–2390
Tomar D, Singh R, Singh AK, Pandya CD, Singh R (2012) TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells. Biochim Biophys Acta Mol Cell Res 1823:316–326
van Gent M, SparrerM KM, Gack U (2018) TRIM proteins and their roles in antiviral host defenses. Annu Rev Virol 5:385–405
Van Tol S, Hage A, Giraldo MI, Bharaj P, Rajsbaum R (2017) The TRIMendous role of TRIMs in virus–host interactions. Vaccines 5(3):23
Vinter H, Langkilde A, Ottosson V, Espinosa A, Wahren-Herlenius M, Raaby L, Johansen C, Iversen L (2017) TRIM 21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model. Exp Dermatol 26(8):713–720
Wada K, Niida M, Tanaka M, Kamitani T (2009) Ro52-mediated monoubiquitination of IKKβ down-regulates NF-κB signalling. J Biochem 146(6):821–832
Weinert C, Morger D, Djekic A, Grütter MG, Mittl PR (2015) Crystal structure of TRIM20 C-terminal coiled-coil/B30. 2 fragment: implications for the recognition of higher order oligomers. Sci Rep 5(1):10819
White E (2015) The role for autophagy in cancer. J Clin Invest 125(1):42–46
Yang L, Jin L, Ke Y, Fan X, Zhang T, Zhang C, Bian H, Wang G (2018a) E3 ligase Trim21 ubiquitylates and stabilizes keratin 17 to induce STAT3 activation in psoriasis. J Invest Dermatol 138(12):2568–2577
Yang SH, Gao CY, Li L, Chang C, Leung PS, Gershwin ME, Lian ZX (2018b) The molecular basis of immune regulation in autoimmunity. Clin Sci 132(1):43–67
Yoshimi R, Chang TH, Wang H, Atsumi T, Morse HC, Ozato K (2009) Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-κB-dependent cytokine expression in fibroblasts. J Immunol 182(12):7527–7538
Yoshimi R, Ishigatsubo Y, Ozato K (2012) Autoantigen TRIM21/Ro52 as a possible target for treatment of systemic lupus erythematosus. Int J Rheumatol 2012:1–11
Zhang J, Fang L, Zhu X, Qiao Y, Yu M, Wang L, Chen Y, Yin W, Hua ZC (2012) Ro52/SSA sensitizes cells to death receptor-induced apoptosis by down-regulating c-FLIP (L). Cell Biol Int 36(5):463–468
Zhang HT, Zeng Q, Wu B, Lu J, Tong KL, Lin J, Liu QY, Xu L, Yang J, Liu X (2021) TRIM21-regulated annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy. Cell Death Dis 12(1):21
Zhang Y, Zhang W, Zheng L, Guo Q (2022) The roles and targeting options of TRIM family proteins in tumor. Front Pharmacol 13:999380
Zhou G, Wu W, Yu L, Yu T, Yang W, Wang P, Zhang X, Cong Y, Liu Z (2018) Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17 cell differentiation in patients with inflammatory bowel diseases. J Allergy Clin Immunol 142(4):1218–1228
Acknowledgements
The authors are thankful for all those who provided assistance in publication.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
ST, AA and MBK searched the literature and wrote the initial draft. ZG and MS revised the initial draft. HA contributed to the study conception and design and edited the final draft. MBK and AA supervised the work and approved the final manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tanveer, S., Afzal, A., Gul, Z. et al. Multifaceted role of TRIM21 in inflammation. BIOLOGIA FUTURA (2024). https://doi.org/10.1007/s42977-024-00221-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42977-024-00221-7